These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8458320)

  • 1. Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.
    Halazonetis TD; Davis LJ; Kandil AN
    EMBO J; 1993 Mar; 12(3):1021-8. PubMed ID: 8458320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PAb240+ conformation of wild type p53 binds DNA.
    McLure KG; Lee PW
    Oncogene; 1996 Sep; 13(6):1297-303. PubMed ID: 8808704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'wildtype' conformation of p53: epitope mapping using hybrid proteins.
    Wang PL; Sait F; Winter G
    Oncogene; 2001 Apr; 20(18):2318-24. PubMed ID: 11402327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group.
    Hansen S; Hupp TR; Lane DP
    J Biol Chem; 1996 Feb; 271(7):3917-24. PubMed ID: 8632013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence.
    Niewolik D; Vojtesek B; Kovarik J
    Oncogene; 1995 Mar; 10(5):881-90. PubMed ID: 7898929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical characterization of different conformational states of the Sf9 cell-purified p53His175 mutant protein.
    Cohen PA; Hupp TR; Lane DP; Daniels DA
    FEBS Lett; 1999 Dec; 463(1-2):179-84. PubMed ID: 10601663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A temperature-sensitive mutant of human p53.
    Zhang W; Guo XY; Hu GY; Liu WB; Shay JW; Deisseroth AB
    EMBO J; 1994 Jun; 13(11):2535-44. PubMed ID: 8013454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
    Hansen S; Lane DP; Midgley CA
    J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A significant decrease of the transcriptional activity of p53 mutants deriving from human functional adrenal tumors.
    Lin SR; Yang YC; Jung JH; Tsai JH
    DNA Cell Biol; 1996 Oct; 15(10):793-803. PubMed ID: 8892752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 DNA binding can be modulated by factors that alter the conformational equilibrium.
    McLure KG; Lee PW
    EMBO J; 1999 Feb; 18(3):763-70. PubMed ID: 9927436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.
    Zhu YM; Bradbury DA; Russell NH
    Br J Cancer; 1994 Mar; 69(3):468-72. PubMed ID: 8123475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
    Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
    J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Hainaut P; Milner J
    Cancer Res; 1993 Oct; 53(19):4469-73. PubMed ID: 8402615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
    Stürzbecher HW; Brain R; Addison C; Rudge K; Remm M; Grimaldi M; Keenan E; Jenkins JR
    Oncogene; 1992 Aug; 7(8):1513-23. PubMed ID: 1321401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature sensitivity for conformation is an intrinsic property of wild-type p53.
    Hainaut P; Butcher S; Milner J
    Br J Cancer; 1995 Feb; 71(2):227-31. PubMed ID: 7841034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-specific interaction of a conformational domain of p53 with DNA.
    Srinivasan R; Roth JA; Maxwell SA
    Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
    Zhu YM; Bradbury D; Russell N
    Br J Cancer; 1993 Nov; 68(5):851-5. PubMed ID: 8217600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
    Brazda V; Muller P; Brozkova K; Vojtesek B
    Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and kinetic analysis of p53-DNA complexes and comparison of human and murine p53.
    Hall AR; Milner J
    Oncogene; 1995 Feb; 10(3):561-7. PubMed ID: 7845681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro analysis of the dominant negative effect of p53 mutants.
    Chène P
    J Mol Biol; 1998 Aug; 281(2):205-9. PubMed ID: 9698540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.